Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/ refractory B cell non-Hodgkin lymphoma Letter uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Hematopoietic Stem Cell Transplantation
  • Lymphoma

publication date

  • January 2019

Research

keywords

  • Letter

Identity

Digital Object Identifier (DOI)

  • 10.1038/s41375-019-0476-y